CMO Recipharm plots a $142M Swedish IPO

Amid the prolonged bull market for life sciences IPOs, a handful of European firms are lining up to test the waters in Europe, including CMO giant Recipharm, which is planning to stage a $142 million offering. The company expects to make its debut on the Swedish market next month, giving it a market cap of up to $500 million. Article